Donanemab detects a minor fraction of amyloid-β plaques in post-mortem brain tissue of patients with Alzheimer's disease and Down syndrome.

ABSTRACT:

SUBMITTER: Bouter Y 

PROVIDER: S-EPMC9038931 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature